Scientists track Long-Term effects of groundbreaking Parkinson's gene therapy
NCT ID NCT07081841
Summary
This study follows people with Parkinson's disease or a related condition who previously received an experimental gene therapy called AB-1005. Researchers want to understand the long-term safety of the treatment and see how well its effects last over time. The study is observational, meaning participants are monitored but do not receive new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University
Columbus, Ohio, 43210, United States
-
University of California San Francisco
San Francisco, California, 94143, United States
Conditions
Explore the condition pages connected to this study.